Real-life experiences with omalizumab for the treatment of chronic urticaria

Annals of Allergy, Asthma and Immunology

Volumn 112, Issue 2, 2014, Pages 170-174

  Sussman, Gordon ^a   Hébert, Jacques ^b   Barron, Carly ^a   Bian, Jia ^a   Caron Guay, Rose Marie ^b   Laflamme, Stéphanie ^b   Stern, Simon ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OMALIZUMAB; PREDNISONE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CHILD; CHRONIC URTICARIA; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COLD URTICARIA; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; REMISSION; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; CANADA; CHILD; CHRONIC DISEASE; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; URTICARIA; YOUNG ADULT;

EID: 84893648040     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.12.005     Document Type: Article

References (28)

1. T. Zuberbier, R. Asero, and C. Bindslev-Jensen et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria Allergy 64 2009 1417 1426
2. R.J. Powell, G.L. Du Toit, and N. Siddique et al. BSACI guidelines for the management of chronic urticaria and angio-oedema Clin Exp Allergy 37 2007 631 650
3. F. Barbosa, J. Freitas, and A. Barbosa Chronic idiopathic urticaria and anxiety symptoms J Health Psychol 16 2011 1038 1047
4. B. Engin, F. Uguz, E. Yilmaz, M. Ozdemir, and I. Mevlitoglu The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria J Eur Acad Dermatol Venereol 22 2008 36 40
5. A.K. Thompson, A.F. Finn, and W.F. Schoenwetter Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria J Am Acad Dermatol 43 2000 24 30
6. E. Toubi, A. Kessel, and N. Avshovich et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients Allergy 59 2004 869 873
7. T. Zuberbier, R. Asero, and C. Bindslev-Jensen et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria Allergy 64 2009 1427 1443
8. A.P. Kaplan Treatment of chronic spontaneous urticaria Allergy Asthma Immunol Res 4 2012 326 331
9. R. Schellenberg, J.D. Adachi, and D. Bowie et al. Oral corticosteroids in asthma: a review of benefits and risks Can Respir J 14 suppl C 2007 1C 7C
10. A. Groffik, H. Mitzel-Kaoukhov, M. Magerl, M. Maurer, and P. Staubach Omalizumab - an effective and safe treatment of therapy-resistant chronic spontaneous urticaria Allergy 66 2011 303 305
11. M. Magerl, P. Staubach, and S. Altrichter et al. Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab J Allergy Clin Immunol 126 2010 665 666
12. C. Vestergaard, and M. Deleuran Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab Acta Derm Venereol 90 2010 443 444
13. Y.H. Nam, J.H. Kim, and H.J. Jin et al. Effects of omalizumab treatment in patients with refractory chronic urticaria Allergy Asthma Immunol Res 4 2012 357 361
14. S. Büyüköztürk, A. Gelincik, M. Demirtürk, E. Kocaturk, B. Colakoǧlu, and M. Dal Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey J Dermatol 39 2012 439 442
15. I. Ivyanskiy, C. Sand, and S.F. Thomsen Omalizumab for chronic urticaria: a case series and overview of the literature Case Rep Dermatol 4 2012 19 26
16. M. Armengot-Carbo, M. Velasco-Pastor, B. Rodrigo-Nicolas, V. Pont-Sanjuan, E. Quecedo-Estebanez, and E. Gimeno-Carpio Omalizumab in chronic urticaria: a retrospective series of 15 cases Dermatol Ther 26 2013 257 259
17. A.C. Lefévre, M. Deleuran, and C. Vestergaard A long term case series study of the effect of omalizumab on chronic spontaneous urticaria Ann Dermatol 25 2013 242 245
18. M. Labrador-Horrillo, A. Valero, and M. Velasco et al. Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice Expert Opin Biol Ther 13 2013 1225 1228
19. A.P. Kaplan, K. Joseph, R.J. Maykut, G.P. Geba, and R.K. Zeldin Treatment of chronic autoimmune urticaria with omalizumab J Allergy Clin Immunol 122 2008 569 573
20. S. Saini, K.E. Rosen, and H.J. Hsieh et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria J Allergy Clin Immunol 128 2011 567 573
21. M. Maurer, S. Altrichter, and T. Bieber et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase J Allergy Clin Immunol 128 2011 202 209
22. M. Maurer, K. Rosén, and H.J. Hsieh et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria N Engl J Med 368 2013 924 935
23. A. Kaplan, D. Ledford, and M. Ashby et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy J Allergy Clin Immunol 132 2013 101 109
24. J.A. Boyce Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE J Allergy Clin Immunol 117 2006 1415 1418
25. P. Brodská, and P. Schmid-Grendelmeier Treatment of severe cold contact urticaria with omalizumab: case reports Case Rep Dermatol 4 2012 275 280
26. A. Le Moing, C. Bécourt, E. Pape, Y. Dejobert, E. Delaporte, and D. Staumont-Sallé Effective treatment of idiopathic chronic cold urticaria with omalizumab: report of 3 cases J Am Acad Dermatol 69 2013 e99 e101
27. C.H. Song, S. Stern, M. Giruparajah, N. Berlin, and G.L. Sussman Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria Ann Allergy Asthma Immunol 110 2013 113 117
28. A. Młynek, A. Zalewska-Janowska, P. Martus, P. Staubach, T. Zuberbier, and M. Maurer How to assess disease activity in patients with chronic urticaria? Allergy 63 2008 777 780